Glibenclamide administration attenuates infarct volume, hemispheric swelling, and functional impairments following permanent focal cerebral ischemia in rats

Stroke Research and Treatment

Volumn , Issue , 2012, Pages

  Wali, Bushra ^a   Ishrat, Tauheed ^a   Atif, Fahim ^a   Hua, Fang ^a   Stein, Donald G ^a   Sayeed, Iqbal ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN INFARCTION; BRAIN INFARCTION SIZE; CONTROLLED STUDY; DISEASE SEVERITY; FUNCTIONAL DISEASE; GRIP STRENGTH; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGICAL SEVERITY SCORE; NONHUMAN; OUTCOME ASSESSMENT; PARIETAL CORTEX; PRIORITY JOURNAL; RAT; SCORING SYSTEM;

EID: 84867386028     PISSN: None     EISSN: 20420056     Source Type: Journal    
DOI: 10.1155/2012/460909     Document Type: Article

References (29)

1. Roger V. L., Go A. S., Lloyd-Jones D. M., Heart disease and stroke statistics2012 update: a report from the American Heart Association. Circulation 2012 125 1 e2 e220
2. Simard J. M., Chen M., Tarasov K. V., Bhatta S., Ivanova S., Melnitchenko L., Tsymbalyuk N., West G. A., Gerzanich V., Newly expressed SUR1-regulated NCCa-ATP channel mediates cerebral edema after ischemic stroke. Nature Medicine 2006 12 4 433 440 2-s2.0-33645733773 10.1038/nm1390
3. Simard J. M., Tsymbalyuk N., Tsymbalyuk O., Ivanova S., Yurovsky V., Gerzanich V., Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke. Stroke 2010 41 3 531 537 2-s2.0-77649132891 10.1161/STROKEAHA.109.572644
4. Simard J. M., Geng Z., Kyoon Woo S., Ivanova S., Tosun C., Melnichenko L., Gerzanich V., Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. Journal of Cerebral Blood Flow and Metabolism 2009 29 2 317 330 2-s2.0-59149087488 10.1038/jcbfm.2008.120
5. Zhou Y., Fathali N., Lekic T., Tang J., Zhang J. H., Glibenclamide improves neurological function in neonatal hypoxia-ischemia in rats. Brain Research 2009 1270 131 139 2-s2.0-67349220683 10.1016/j.brainres.2009.03.010
6. Nistico R., Piccirilli S., Sebastianelli L., Nisticò G., Bernardi G., Mercuri N. B., The blockade of K(+)-ATP channels has neuroprotective effects in an in vitro model of brain ischemia. International Review of Neurobiology 2007 82 383 395
7. Pompermayer K., Amaral F. A., Fagundes C. T., Vieira A. T., Cunha F. Q., Teixeira M. M., Souza D. G., Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury. European Journal of Pharmacology 2007 556 13 215 222 2-s2.0-33846116632 10.1016/j.ejphar.2006.10.065 (Pubitemid 46074006)
8. Da Silva-Santos J. E., Santos-Silva M. C., De Queiroz Cunha F., Assreuy J., The role of ATP-sensitive potassium channels in neutrophil migration and plasma exudation. Journal of Pharmacology and Experimental Therapeutics 2002 300 3 946 951 2-s2.0-0036179266 10.1124/jpet.300.3.946 (Pubitemid 34165000)
9. Pompermayer K., Souza D. G., Lara G. G., Silveira K. D., Cassali G. D., Andrade A. A., Bonjardim C. A., Passaglio K. T., Assreuy J., Cunha F. Q., Vieira M. A. R., Teixeira M. M., The ATP-sensitive potassium channel blocker glibenclamide prevents renal ischemia/reperfusion injury in rats. Kidney International 2005 67 5 1785 1796 2-s2.0-20244364826 10.1111/j.1523-1755.2005. 00276.x (Pubitemid 40577713)
10. Al-Azzam S. I., Abdul-Razzak K. K., Jaradat M. W., The nephroprotective effects of pioglitazone and glibenclamide against gentamicin-induced nephrotoxicity in rats: a comparative study. Journal of Chemotherapy 2010 22 2 88 91 2-s2.0-77951615574
11. Nazaroglu N. K., Sepici-Dincel A., Altan N., The effects of sulfonylurea glyburide on superoxide dismutase, catalase, and glutathione peroxidase activities in the brain tissue of streptozotocin-induced diabetic rat. Journal of Diabetes and its Complications 2009 23 3 209 213 2-s2.0-65249118833 10.1016/j.jdiacomp.2007.09.001
12. Abdallah D. M., Nassar N. N., Abd-El-Salam R. M., Glibenclamide ameliorates ischemia-reperfusion injury via modulating oxidative stress and inflammatory mediators in the rat hippocampus. Brain Research 2011 1385 257 262 2-s2.0-79953217670 10.1016/j.brainres.2011.02.007
13. Fisher M., Recommendations for advancing development of acute stroke therapies: stroke Therapy Academic Industry Roundtable 3. Stroke 2003 34 6 1539 1546 2-s2.0-0037975646 10.1161/01.STR.0000072983.64326.53 (Pubitemid 36693531)
14. Fisher M., Feuerstein G., Howells D. W., Hurn P. D., Kent T. A., Savitz S. I., Lo E. H., Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009 40 6 2244 2250 2-s2.0-66849097996 10.1161/STROKEAHA.108.541128
15. Dirnagl U., Kaplan B., Jacewicz M., Pulsinelli W., Continuous measurement of cerebral cortical blood flow by Laser-Doppler flowmetry in a rat stroke model. Journal of Cerebral Blood Flow and Metabolism 1989 9 5 589 596 2-s2.0-0024439730 (Pubitemid 19239477)
16. Longa E. Z., Weinstein P. R., Carlson S., Cummins R., Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989 20 1 84 91 2-s2.0-0024494427 (Pubitemid 19040218)
17. Bederson J. B., Pitts L. H., Germano S. M., Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986 17 6 1304 1308 2-s2.0-0022870943 (Pubitemid 17008976)
18. Belayev L., Busto R., Zhao W., Fernandez G., Ginsberg M. D., Middle cerebral artery occlusion in the mouse by intraluminal suture coated with poly-L-lysine: neurological and histological validation. Brain Research 1999 833 2 181 190 2-s2.0-0033519889 10.1016/S0006-8993(99)01528-0 (Pubitemid 29333792)
19. Xia C. F., Smith R. S., Shen B., Yang Z. R., Borlongan C. V., Chao L., Chao J., Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor. Hypertension 2006 47 4 752 761 2-s2.0-33645829048 10.1161/01.HYP. 0000214867.35632.0e (Pubitemid 43740248)
20. Ayata C., Ropper A. H., Ischaemic brain oedema. Journal of Clinical Neuroscience 2002 9 2 113 124 2-s2.0-0036242544 10.1054/jocn.2001.1031 (Pubitemid 34464579)
21. Ortega F. J., Gimeno-Bayon J., Espinosa-Parrilla J. F., ATP-dependent potassium channel blockade strengthens microglial neuroprotection after hypoxia-ischemia in rats. Experimental Neurology 2012 235 1 282 296
22. Tomiyama Y., Brian J. E. Jr., Todd M. M., Cerebral blood flow during hemodilution and hypoxia in rats: role of ATP-sensitive potassium channels. Stroke 1999 30 9 1942 1948 2-s2.0-0032825260 (Pubitemid 29411839)
23. Kassem-Moussa H., Graffagnino C., Nonocclusion and spontaneous recanalization rates in acute ischemic stroke: a review of cerebral angiography studies. Archives of Neurology 2002 59 12 1870 1873 2-s2.0-0036897054 10.1001/archneur.59.12.1870 (Pubitemid 35424643)
24. Pantano P., Caramia F., Bozzao L., Dieler C., Von Kummer R., Delayed increase in infarct volume after cerebral ischemia: correlations with thrombolytic treatment and clinical outcome. Stroke 1999 30 3 502 507 2-s2.0-0033004693 (Pubitemid 29115383)
25. Hacke W., Brott T., Caplan L., Meier D., Fieschi C., Von Kummer R., Donnan G., Heiss W. D., Wahlgren N. G., Spranger M., Boysen G., Marler J. R., Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology 1999 53 7, supplement 4 S3 S14 2-s2.0-0032744573 (Pubitemid 29491978)
26. Ishrat T., Sayeed I., Atif F., Stein D. G., Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats. Brain Research 2009 1257 94 101 2-s2.0-63349089474 10.1016/j.brainres.2008.12.048
27. Eltzschig H. K., Eckle T., Ischemia and reperfusionfrom mechanism to translation. Nature Medicine 2011 17 11 1391 1401
28. Broughton B. R. S., Reutens D. C., Sobey C. G., Apoptotic mechanisms after cerebral ischemia. Stroke 2009 40 5 e331 e339 2-s2.0-65549098614 10.1161/STROKEAHA.108.531632
29. Yakovlev A. G., Faden A. I., Caspase-dependent apoptotic pathways in CNS injury. Molecular Neurobiology 2001 24 13 131 144 2-s2.0-0035691186 10.1385/MN:24:1-3:131 (Pubitemid 34066682)